Bolt Biotherapeutics, Inc. earnings per share and revenue

BOLT earnings per share for the last quarter are -0.42 USD whereas the estimation was -0.38 USD which accounts for -10.53% surprise. Company revenue for the same period amounts to 10.00 k USD despite the estimated figure of 775.67 k USD. Estimated earnings per share for the next quarter are -0.35 USD, and revenue is expected to reach 757.25 k USD. Also watch annual changes over time to get a bigger picture of BOLT earnings per share and revenue dynamics.